Literature DB >> 2561182

Efficacy of itraconazole in blastomycosis in a murine model and comparison with ketoconazole.

E G Arathoon, E Brummer, D A Stevens.   

Abstract

Mice were infected intranasally with B. dermatitidis yeasts, and after infection treated orally. Itraconazole 50-150 mg/kg/day was protective (prolonged survival) against lethal infection, although the infection was not sterilized. Itraconazole was approximately 3 times as potent as ketoconazole. These results suggest advantages for itraconazole therapy clinically.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2561182     DOI: 10.1111/j.1439-0507.1989.tb02300.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

Review 1.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.

Authors:  A M Sugar; X P Liu
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Efficacy of nikkomycin Z against experimental pulmonary blastomycosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  SCH 39304 in the treatment of acute or established murine pulmonary blastomycosis.

Authors:  E Brummer; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

5.  An imported case of Blastomyces dermatitidis infection in Mexico.

Authors:  Roberto Velázquez; B Muñoz-Hernández; R Arenas; M L Taylor; F Hernández-Hernández; M E Manjarrez; R López-Martínez
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

6.  Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.

Authors:  E Brummer; P R Bhagavathula; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.